tiprankstipranks
Trending News
More News >
Nkarta, Inc. (NKTX)
:NKTX
US Market
Advertisement

Nkarta (NKTX) Drug Pipeline

Compare
679 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Cyclophosphamide, Fludarabine, Nkx019
Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase I
Recruiting
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Participants With Immune-Mediated Diseases (Ntrust-2)
Dec 04, 2024
Nkx019, Fludarabine, Cyclophosphamide
Lupus Nephritis, Primary Membranous Nephropathy, Glomerulonephritis
Phase I
Recruiting
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)
Jul 10, 2024
Nkx019
Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Waldenstrom Macroglobulinemia, Large B-Cell Lymphoma, Large-Cell Lymphoma, B-Cell Acute Lymphoblastic Leukemia, Indolent Lymphoma, Aggressive Lymphoma
Phase I
Active Not Recruiting
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Aug 20, 2021
Nkx101 - Car Nk Cell Therapy
Aml, Adult, Relapsed/Refractory Aml, Mds, Refractory Myelodysplastic Syndromes
Phase I
Active Not Recruiting
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
Sep 25, 2020

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Nkarta, Inc. (NKTX) have in its pipeline
      NKTX is currently developing the following drugs: Cyclophosphamide, Fludarabine, Nkx019, Nkx019, Fludarabine, Cyclophosphamide, Nkx019. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis